ABL1 and neurodegenerative disease: The discovery of alternatively phosphorylated forms of α‐synuclein, and particularly phosphorylation at Tyr39 (pY39)28 and Tyr125 (pY125)59 by c‐Abl, raised the possibility that c‐Abl could be a key player in the neurodegenerative disease process.